Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 10 of 33
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Issue Information
    (Wiley, 2023-03)
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Maternal Fetal Health
    (Wiley, 2020-08)
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Gynecologic Oncology
    (Wiley, 2020-08)
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Maternal group B Streptococcus colonization: Correlation between IL-6/IL-15 cytokine profiles and infection biomarkers for early risk prediction
    (Mongolian National University of Medical Sciences, 2026-03-30)
    Han Wu, Ri Han Wu
    ;
    Batu, Baoyin Batu
    ;
    ; ;
    Objective: To investigate the risk factors for adverse pregnancy outcomes in women with late-trimester Group B Streptococcus (GBS) colonization and to evaluate the predictive value of serum C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and interleukin-15 (IL-15) as biomarkers for these outcomes. Methods: This is a prospective cohort study of 160 women (80 GBS-positive and 80 GBS-negative). Clinical data, serum biomarkers (CRP, PCT, IL-6, IL-15), and vaginal secretion samples were collected. Statistical analyses were performed to identify independent risk factors and to assess the diagnostic accuracy of the biomarkers using receiver operating characteristic (ROC) curves. Results: Independent risk factors for adverse pregnancy outcomes in GBS-colonized women include advanced maternal age, gestational diabetes mellitus, a history of miscarriage, and vaginal dysbiosis. The combined measurement of CRP, PCT, IL-6, and IL-15 showed superior predictive value for adverse pregnancy outcomes (AUC = 0.913; 95% CI, 0.85-0.97) compared to individual markers. GBS-positive women exhibited a higher incidence of co-infections and adverse neonatal outcomes, such as pneumonia and asphyxia. Conclusion: TA combination of inflammatory biomarkers can serve as a strong predictor of adverse pregnancy outcomes in women with late-stage GBS colonization. These findings support incorporating biomarker testing into GBS screening protocols to enhance risk assessment and guide clinical management.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Milk Fat Globules: 2024 Updates
    (2024)
    Maheshwari, Akhil
    ;
    Mantry, Harshvardhan
    ;
    Bagga, Nitasha
    ;
    Frydrysiak-Brzozowska, Adrianna
    ;
    Milk fat globules (MFGs) are a remarkable example of nature's ingenuity. Human milk (HM) carries contains 3-5% fat, 0.8-0.9% protein, 6.9-7.2% carbohydrate calculated as lactose, and 0.2% mineral constituents. Most of these nutrients are carried in these MFGs, which are composed of an energy-rich triacylglycerol (TAG) core surrounded by a triple membrane structure. The membrane contains polar lipids, specialized proteins, glycoproteins, and cholesterol. Each of these bioactive components serves important nutritional, immunological, neurological, and digestive functions. These MFGs are designed to release energy rapidly in the upper gastrointestinal tract and then persist for some time in the gut lumen so that the protective bioactive molecules are conveyed to the colon. These properties may shape the microbial colonization and innate immune properties of the developing gastrointestinal tract. Milk fat globules in milk from humans and ruminants may resemble in structure but there are considerable differences in size, profile, composition, and specific constituents. There are possibilities to not only enhance the nutritional composition in a goal-oriented fashion to correct specific deficiencies in the infant but also to use these fat globules as a nutraceutical in infants who require specific treatments. To mention a few, there might be possibilities in enhancing neurodevelopment, in defense against gastrointestinal and respiratory tract infections, improving insulin sensitivity, treating chronic inflammation, and altering plasma lipids. This review provides an overview of the composition, structure, and biological activities of the various components of the MFGs. We have assimilated research findings from our own laboratory with an extensive review of the literature utilizing key terms in multiple databases including PubMed, EMBASE, and Science Direct. To avoid bias in the identification of studies, keywords were short-listed a priori from anecdotal experience and PubMed's Medical Subject Heading (MeSH) thesaurus.
  • Some of the metrics are blocked by your 
    Item type:Publication,